Nurami Medical has raised $11 million from equity investments and Israel Innovation Authority (IIA) grants. Its most recent round of $5 million was completed in Sept. 2020.
Nurami Medical plans to continue to apply to the IIA for additional non-dilutive funding in the development of new products.
We invite you to join us on our journey for the development and commercialization of novel regenerative medicine solutions.
NURAMI MEDICAL TARGETS LARGE
AND GROWING MARKETS
Global Soft Tissue
Nurami Medical targets the global soft tissue repair market which reached $16.5 billion in 2017, and is poised to reach $25.6 billion in 2024. The tissue mesh segment comprised 37.5% of this market for over $6 billion.
Nurami Medical ‘s preliminary target is the dural repair market. According to Allied Market Research the soft tissue dural repair market reached $1.35 billion in 2017, and is projected to reach $2.14 billion by 2025, growing at a CAGR of 5.9% through 2025. Nurami Medical targets a $1 billion dural grafts and sealant market which is poised to grow to reach over $1.4 billion in 2025.
The global surgical sealants and adhesives market reached over $1.5 billion in 2016, and is expected to grow at a 7.6% CAGR from 2017 through 2024 to reach $2.8 billion. Nurami Medical’s novel sealant targets this large and growing market.